[Verse 1]
Scalpel to the stomach, rerouting what we know,
Bariatric intervention — watch the excess go,
Excess body weight drops fifty to seventy percent,
Roux-en-Y or sleeve, the metabolic covenant,
Comorbidities dissolving like they never held a claim,
Sleep apnoea retreating, blood pressure not the same,
Hypertension walking backwards out the clinical door,
Dyslipidaemia clearing — that's what surgery's for
[Chorus]
Four outcomes, lock 'em in — Weight, Comorbid, Mortality, Metabolic win,
Diabetes bending knee before the anastomosis,
GLP-1 riding shotgun — call it symbiosis,
Four outcomes, carve 'em deep — resolution while you sleep,
Survival curves diverging, that's the benefit we keep,
Weight, Comorbid, Death, Diabetes — four, repeat
[Verse 2]
Now mortality — the Swedish Obese Subjects told the tale,
Twenty-nine percent reduction, tipping the actuarial scale,
Cardiovascular events collapsing in the data,
Long-term follow-up vindicates the operating theatre,
Not cosmetic trimming — this is longevity architecture,
Visceral adiposity excised like a malefactor,
The hazard ratio shrinks below the line of one,
Survival advantage quantified, the evidence has won
[Chorus]
Four outcomes, lock 'em in — Weight, Comorbid, Mortality, Metabolic win,
Diabetes bending knee before the anastomosis,
GLP-1 riding shotgun — call it symbiosis,
Four outcomes, carve 'em deep — resolution while you sleep,
Survival curves diverging, that's the benefit we keep,
Weight, Comorbid, Death, Diabetes — four, repeat
[Verse 3]
Type two diabetes — metabolic surgery's crown jewel,
Remission rates of eighty percent, the mechanism's dual,
Foregut exclusion shifting incretin biology rapid,
Caloric restriction plus the hormonal — never flaccid,
GLP-1 secretion amplified post-bypass,
Semaglutide alongside — adjuvant, unsurpassed,
Receptor agonists potentiating what the knife began,
Pharmacology and surgery — a combinatorial plan
[Bridge]
Here's your rare word — pleiotropic — meaning many-faced effect,
GLP-1 agonists pleiotropic — cardio, renal, correct,
Not just glucose-lowering — weight and inflammation too,
Pleiotropic action, multiple pathways pushing through,
Surgery reshapes anatomy, the drug refines the rest,
Dual mechanism, dual target — conjoint manifest
[Verse 4]
Comorbidity resolution — frame it in a hierarchy,
Diabetes first, then hypertension, then the apnoea trilogy,
GORD improving after sleeve debated in the text,
Post-bypass GORD resolves — procedure context,
Excess weight loss plateaus around the eighteen-month mark,
Maintenance needs behaviour — sustain beyond the spark,
Revision surgery exists when primary outcomes wane,
Longitudinal surveillance — audit every gain